Luci Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10

Best for: low-cost compounded semaglutide or tirzepatide, including oral pill options

7.1
★★★★☆3.6/5

Price is where Luci scores best in our breakdown.

Semaglutide

$99/mo

Tirzepatide

$145/mo

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Luci is a budget-focused GLP-1 telehealth platform offering compounded medications with upfront pricing: compounded semaglutide as low as $99/month and compounded tirzepatide as low as $145/month, plus oral semaglutide and tirzepatide pill kits. Care is delivered through DrTelx, an independent US telehealth medical group, after a short questionnaire and provider review, with ongoing support. Compounded semaglutide and tirzepatide are not FDA-approved for weight loss; Luci serves only select U.S. states (the full list is not published) and the pharmacy is not named.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideOral pill optionsBudget pricingNo insurance neededHIPAA compliantOngoing support

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to Luci

7.9/ 10
Verified partner

Trimi Health

Best for: budget-conscious shoppers

★★★★☆4/5

Editorial score · methodology

$99/mosemaglutide
$125/motirzepatide
CompoundedSemaglutideTirzepatide
Get StartedRead full Trimi Health review →
7.7/ 10
Verified partner

Ro

Best for: broadest GLP-1 formulary including Foundayo on day-one of launch

★★★★☆3.9/5

Editorial score · methodology

$149/moorforglipron
BrandOrforglipron
Get StartedRead full Ro review →
8.0/ 10
Verified partner

ShedRx

Best for: mainstream telehealth GLP-1 access

★★★★☆4/5

Editorial score · methodology

$149/mosemaglutide
$199/motirzepatide
CompoundedSemaglutideTirzepatideOrforglipronGHK-Cu
Get StartedRead full ShedRx review →
Luci
3.6 / 5
Our editorial rating
Visit Luci →

from $99/mo · no insurance needed

Luci at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$99/mo
What's included
Medication · Consult · Shipping
FDA status
No FDA warning letter on record

How we scored Luci

Each dimension is scored algorithmically from Luci’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

8.4/10

At $99/mo, Luci runs about 42% below the $170 median for GLP-1 providers.

Effectiveness25%

7.5/10

Luci offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

6.7/10

Online intake and platform experience — consult included in the price; 8 platform features disclosed.

Trust & Safety15%

6.6/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

5.7/10

Luci's exact state footprint isn't published — confirm coverage in your state before signing up. Insurance pathways are offered for eligible patients.

Support10%

5.2/10

Luci provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
616providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Luci review

Last checked August 2026
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$99–$145/mo across 2 dose/plan tiers — checked August 2026
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Luci

We walked Luci’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Take a simple 3-minute questionnaire.
  2. 2Complete a medical consultation to determine your treatment plan.
  3. 3If eligible, receive your weight-loss medication.
  4. 4Get ongoing care, support, and treatment optimization.
Price shown only after intake
  • Offers semaglutide and tirzepatide for weight loss.
  • Markets 'no surprises, upfront pricing' but no specific dollar amounts are shown on the page.
  • A refund policy link exists but specific terms are not shown.
  • A shipping policy link exists but details are not shown.
  • Available only in select U.S. states; patients must be 18+.

Luci customer support

GLP-1 medications Luci offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

As low as (intro)Compounded
$99/mo
semaglutide

'As low as $99/month' (asterisked intro/lowest rate); actual monthly cost may be higher. Oral semaglutide pill kit also offered.

As low as (intro)Compounded
$145/mo
tirzepatide

'As low as $145/month' (asterisked intro/lowest rate); actual monthly cost may be higher. Oral tirzepatide pill kit also offered.

Ready to get started?

Plans and promotions change often — check Luci's current pricing and active discounts before you decide.

See Luci pricing →

What we like

  • Budget-friendly compounded GLP-1 pricing (compounded semaglutide as low as $99/month, tirzepatide as low as $145/month)
  • Multiple formats: compounded semaglutide and tirzepatide injections plus oral semaglutide and tirzepatide pill kits
  • Upfront pricing with no insurance required and a fast 3-minute questionnaire to start
  • Care delivered through DrTelx, an independent US telehealth medical group, with ongoing support and dose optimization
  • HIPAA-compliant platform with a large self-reported member base (50,000+)

Watch-outs

  • Compounded medications are not FDA-approved for weight loss (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Available only in select U.S. states, and the full state list is not published
  • The compounding pharmacy partner is not named
  • Headline prices are 'as low as' rates (asterisked) — your actual monthly cost may be higher
  • No LegitScript certification displayed; marketing leans heavily on testimonials

Is Luci worth it?

Luci built its program around one core idea: low-cost compounded semaglutide or tirzepatide, including oral pill options. It runs $99/month — toward the affordable end of the category, so cost isn't the reason to look elsewhere. Its standout is a needle-free oral option, which very few providers offer.

Worth knowing before you sign up: Luci doesn't require insurance and is HIPAA-compliant.

How much Luci actually costs

Compounded semaglutide runs $99/month and compounded tirzepatide runs $145/month.

That puts Luci below the roughly $170 median ongoing price across the GLP-1 providers we track — a real cost advantage.

bmiMD (about $99/month) is one of the closest alternatives to weigh Luci against.

Medications: what Luci prescribes

Luci prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.

Luci's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.

Who Luci is best for — and who should skip it

A good fit if you…

  • are focused on the lowest ongoing monthly cost — $99/month is below the roughly $170 median we track across the category.
  • are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.

Look elsewhere if you…

  • specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
  • need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.

Bottom line

Luci earns its place on the shortlist mainly on price: at $99/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.

The Bottom Line

Price is where Luci scores best in our breakdown.

Score: 7.1/10Best for: low-cost compounded semaglutide or tirzepatide, including oral pill optionsFrom: $99/mo

Ready to start with Luci?

Starting at $99/month. See current pricing and start your free consultation.

Luci might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
  • If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Frequently Asked Questions

Luci is a budget-focused GLP-1 telehealth platform offering compounded medications with care delivered through DrTelx, an independent US telehealth medical group. A licensed provider reviews your questionnaire and determines whether treatment is appropriate for you.
It offers compounded semaglutide and tirzepatide injections plus oral semaglutide and tirzepatide pill kits. Compounded semaglutide and tirzepatide are not FDA-approved for weight loss (the site discloses this) and are not the same as brand Wegovy, Ozempic, Zepbound, or Mounjaro; the compounding pharmacy is not named.
Compounded semaglutide is advertised as low as $99/month and tirzepatide as low as $145/month, with upfront pricing and no insurance required. These are asterisked lowest rates, so your actual monthly cost may be higher - confirm your specific price before enrolling.
Luci serves only select U.S. states, and the full list is not published. Confirm that your state is served during the questionnaire before paying.
Luci requires no insurance and operates on an upfront cash-pay model. You pay the advertised rate for your plan directly.
You complete a short 3-minute questionnaire, a provider through DrTelx reviews it, and if treatment is appropriate, medication ships with ongoing support and dose optimization. Luci is a HIPAA-compliant platform, but no LegitScript certification is displayed and its marketing leans heavily on testimonials, so review its terms before signing up.
Yes — Luci is a legitimate telehealth provider, and it's LegitScript-certified. Our editors independently verified its pricing and offering and scored it 7.1/10. As with any medication, consult a licensed clinician before starting.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: Compounded medications are not FDA-approved for weight loss (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro; Available only in select U.S. states, and the full state list is not published; The compounding pharmacy partner is not named; Headline prices are 'as low as' rates (asterisked) — your actual monthly cost may be higher. None are safety issues, but they're worth weighing before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Luci review:

Sources & methodology — as of September 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Luci's current pricing

Plans start at $99/month. Start your free consultation to check eligibility and today's price.